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Neuronal communication relies on the fusion of neurotrans-
mitter-containing vesicles with the plasma membrane. The sol-
uble N-ethylmaleimide-sensitive fusion protein attachment
protein receptor (SNARE) proteins initiate membrane fusion
through the formation of the SNARE complex, a process tightly
regulated by Sec1/Munc18-1 (SM) proteins. The emerging
trend is that SMproteins promote SNARE-mediatedmembrane
fusion by binding to a Syntaxin N-terminal motif. Here we
report that mutations in the hydrophobic pocket of Munc18-1
(F115E and E132A), predicted to disrupt the N-terminal Sx1a
interaction have a modest effect on binding to Sx1a in its free
state, but abolish binding to the SNARE complex. Overexpres-
sion of the Munc18-1 mutant in PC12 cells lacking Munc18-1
rescues both neuroexocytosis and the plasma membrane local-
ization of Syntaxin. However, total internal reflection fluo-
rescence microscopy analysis reveals that expression of a
Munc18-1 double mutant reduces the rate of vesicle fusion, an
effect only detectable at the onset of stimulation. TheMunc18-1
hydrophobic pocket is therefore critical for SNARE complex
binding. However, mutations abrogating this interaction have a
limited impact on Ca2-dependent exocytosis in PC12 cells.
Following stimulation of neurons, a number of well orches-
trated protein/protein (1) and protein/lipid (2) interactions
underpin the fusion of secretory vesicles with the presynaptic
plasma membrane. In this sequence of interactions, vesicles
approach the plasma membrane (tethering and docking),
undergo priming and, upon Ca2 influx, fuse with the plasma
membrane, thereby releasing neurotransmitter into the synap-
tic cleft (1). Vesicular exocytosis relies on the function of solu-
bleN-ethylmaleimide-sensitive fusion protein attachment pro-
tein receptor (SNARE)2 proteins as demonstrated by the
blockade of neuroexocytosis following SNAREprotein cleavage
by clostridial neurotoxins (3). One of the key players in SNARE
regulation is the cytosolic regulatory protein, Munc18-1
(Munc18a, nsec-1) (4–7). Although the function of SNARE
proteins in mediating exocytosis is well established (2, 8), the
precise role ofMunc18-1 in exocytosis is still a subject of heated
debate (6, 7, 9, 10).
Munc18-1 belongs to the Sec1/Munc18 (SM) family of pro-
teins that are involved in mediating membrane trafficking
events (11–13). Mutations in these proteins have recently
been associated with infantile epileptic encephalopathy (14).
Although the function of Munc18-1 and its interaction with
SNAREs have been studied for over 10 years, the molecular
mechanism ofMunc18-1 regulation of membrane fusion is still
not clear. Munc18-1 was originally characterized as a negative
regulator of exocytosis as it binds to the target membrane
SNARE, Syntaxin 1a (Sx1a) (5) in a conformation that seques-
ters the Sx1a SNAREhelix and inhibits SNARE complex forma-
tion (7, 15).Other SMproteins have been shown to bind to their
cognate syntaxins via an N-terminal motif (16–19), allowing
interactions that are associated with a positive role for SM pro-
teins in SNARE-mediated membrane fusion (20). Despite bio-
chemical evidence supporting a negative regulatory role for
Munc18-1, there is strong genetic evidence for a critical posi-
tive role for Munc18-1 in exocytosis, as demonstrated by a
Munc18-1 knock-out mouse that exhibits a complete blockage
of neurotransmission (21).
Recently, a short N-terminal peptide from Sx1a was also
shown to bind to Munc18-1 via a novel interaction that pro-
motes SNARE-mediated fusion of liposomes in vitro (6).
Moreover, the N-terminal truncation of Sx1a only affects the
binding of the open conformation of Sx1a to Munc18-1
occurring near the plasma membrane (10). Oddly, the
Munc18-1-Sx1a interaction in solution predominantly in-
volves the closed conformation (10), which raises the ques-
tion of the relative contribution of the Sx1a N terminus to
the overall Munc18-1-Sx1a interaction.
To address the functional significance of the N-terminal
interaction, we took a reverse strategy and investigated the
molecular nature of the binding of Munc18-1 to the Sx1a N
terminus and to the SNARE complex. We mutated Munc18-1:
Phe115 and Glu132, which are located in an evolutionarily con-
served surface pocket of Munc18-1 (17, 22). We found that
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whereas these mutations have only a mild effect on the binding
of Munc18-1 to Sx1a in its free state, they completely abrogate
Munc18-1 binding to the SNARE complex. Expression of these
mutants in PC12 cells lackingMunc18-1 rescues exocytosis to a
similar extent to that obtained with Munc18-1-WT. Total
internal reflection fluorescence (TIRF) microscopy of vesicle
docking at the cell surface reveals that these mutations support
exocytosis. However, the rate of vesicle fusion is markedly
reduced at the onset of stimulation, arguing for a role of
Munc18-1 in regulating the dynamics of SNARE-mediated ves-
icle fusion during exocytosis.
EXPERIMENTAL PROCEDURES
Munc18-1-Sx1aModel—Coordinates for theMunc18c-Sx4-
(1–29) complex (Protein Data Bank code 2PJX) and the
Munc18-1:Sx1a complexes (PDB code 1DN1) were obtained
from the Protein Data Bank. Analysis was performed using
MacPymol (PyMol, W. L. DeLano). A model for Sx1a peptide
binding to domain 1 of Munc18-1 was constructed in the fol-
lowing way: the crystal structure of Munc18-1 was superim-
posed onto the crystal structure of Munc18c (from the
Munc18c-Sx4-(1–29) complex). The peptide binding site of
theMunc18c-Sx4-(1–29) complex was compared with the cor-
responding region in the overlaid Munc18-1 crystal structure.
Residues in the Sx4 peptide of the crystal structure of the
Munc18c-Sx4-(1–29) complex were mutated in silico to the
corresponding Sx1a residues. Sequences were aligned using
ClustalW (23). Figures showing model or crystal structures
were generated using MacPymol.
Constructs—Expression of recombinant full-length rat GST-
Munc18-1 (GST-Munc18-1-WT) in the pGEX-KG vector has
been described previously (24). Various point mutants (GST-
Munc18-1-F115E, GST-Munc18-1-E132A, and GST-Munc18-
1-F115E/E132A) were constructed from the GST-Munc18-1
pGEX-KG vector using a QuikChange site-directed mutagenesis
kit (Stratagene) and mutation primers as follows: GST-
Munc18-1-F115E, forward 5-CATGTCCAGATGCCCT-
GGAAAACGAGCTGGTAAAATC-3 and reverse, 5-GAT-
TTTACCAGCTCGTTTTCCAGGGCATCTGGACATG-3;
GST-Munc18-1-E132A, forward 5-CATCAAGACGCTGAC-
GGCAATCAACATTGCGTTTC-3 and reverse, 5-GTAGTT-
CTGCGACTGCCGTTAGTTGTAACGCAAAG-3.
A C-terminal truncated GST-Munc18-1 mutant (GST-
Munc18-1-dom1, residues 1–132) was constructed by intro-
ducing a STOP codon at bp 394 (Gly to Thr) using the
QuikChange kit. An N-terminal truncated Munc18-1 mutant
(GST-Munc18-1-dom2/3, residues 132–594) was constructed
by introducing an EcoRI site at residue 132 by mutagenesis
(primers: forward, 5-CATCAAGACGCTGACGGAATTCA-
ACATTGCGTTTC-3 and reverse, 5-GAAACGCAATGTT-
GAATTCCGTCAGCGTCTTGATG-3). After digestion with
EcoRI, the fragment corresponding to residues 132–594 was
ligated into pGEX-KG also digested with EcoRI. pCMV5-
Munc18-1-F115E/E132A plasmids containing the silent muta-
tions were constructed using the same strategy using pCMV5-
Munc18-1-WT as template. Neuropeptide Y (NPY)-Venus and
pXGHF-human growth hormone (hGH) were also used to
transfect PC12-KD43 cells as previously described (25).
Recombinant Proteins and SNARE Complex Production—
GST-VAMP2 (residues 1–94) and GST-SNAP25 (residues
1–206) were both expressed in pGEX-KG. All GST fusion pro-
teins were expressed in Escherichia coli by autoinduction in
pGEX-KG. His6-tagged Sx1a (Sx1a-His) (residues 1–265) was
also expressed in pHO4c using the autoinduction method. All
GST fusion proteins were purified using similar methods to
those previously described (18). The GST tag was cleaved from
purified GST-Munc18-1 proteins using bovine thrombin over-
night at room temperature in standard buffer (25 mM HEPES,
pH 7.4, 150 mM NaCl, 2 mM -mercaptoethanol) containing 3
mM CaCl2. GST-SNAP25 was eluted from glutathione beads
with standard buffer containing 20 mM glutathione. His6-
tagged Sx1a was purified using Co2-affinity beads (Scientifix)
in standard buffer containing 20 mM imidazole, pH 7.4, then
eluted with standard buffer containing 500 mM imidazole,
pH 7.4.
The SNARE complex was produced by combining Sx1a-His,
GST-SNAP25, and VAMP2 in a 1:1.5:2 ratio and incubating
overnight at 4 °C in standard buffer containing 0.1% Triton
X-100 and 20 mM imidazole, pH 7.4. The complex was isolated
on Co2-affinity beads via the His tag on Sx1a.
Circular Dichroism—Detagged Munc18-1-WT (1.3 mg/ml),
Munc18-1-F115E (1.3 mg/ml), Munc18-1-E132A (2.3 mg/ml),
and Munc18-1-F115E/E132A (2.3 mg/ml) were analyzed by
circular dichroism to whether the mutation caused changes in
the protein secondary structure compared with Munc18-1-
WT. Five replicates of each spectrumweremeasured on a J-810
polarimeter (Jasco) in a quartz demountable cuvettewith a path
length of 0.01 cm (Hellma) using a dwell time of 1 s, a scanning
speed of 50 nm/min, and data pitch of 1 nm.
Pulldown Binding Assays—Pulldown assays were performed
by first isolating tagged proteins on affinity beads, then incubat-
ing with a molar excess of purified protein in solution. For all
pulldown assays, the concentration of protein bound to the
beads was quantified by densitometry using ImageJ and a
bovine serum albumin standard curve. For the pulldown assay
with Munc18-1-WT point and truncated mutants, a 3-fold
molar excess of detaggedMunc18was incubatedwith Sx1a-His
beads in standard buffer containing 20 mM imidazole, pH 7.4,
and 0.1% Triton X-100. Munc18-1-WT or mutant binding to
Sx1a was quantified by densitometry using ImageJ and com-
pared for three independent experiments. For SNARE complex
pulldown assays, SNARE complex-bound beads were incu-
bated with a 3-fold molar excess of Munc18-1-WT, Munc18-
1-F115E, orMunc18-1-F115E/E132A at 4 °C in standard buffer
containing 0.1% Triton X-100 and 20 mM imidazole, pH 7.4.
After extensive washing, proteins bound to beads were ana-
lyzed by SDS-PAGE using standard procedures. Western blot
was performed for detection of Munc18-1 using anti-
Munc18-1 antibody (rabbit polyclonal, Synaptic Systems).
Isothermal Titration Calorimetry (ITC)—Syntaxin1a-(2–
243) was prepared as previously described (26).Munc18-1-WT
and Munc18-1-F115E/E132A used for the ITC experiment
were prepared as previously described (18). All proteins were
further purified by gel filtration chromatography into 20 mM
sodium phosphate buffer, pH 7.5, 150 mM NaCl, and 1 mM
dithiothreitol (ITC buffer). ITCwas carried out at 298 K using a
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MicroCal iTC200, with 13  3.1-l injections of 25 M Sx1a-
(2–243) (30 g in 40 l) into 2.5 M Munc18-1-WT or
Munc18-1-F115E/E132A (32 g in 200 l). Integration of the
titration curves was performed using ORIGIN to extract ther-
modynamic parameters, stoichiometryN, equilibrium associa-
tion constant Ka (Kd1) and the binding enthalpy H. The
Gibbs free energy of binding G was calculated from the rela-
tionGRT ln(Ka) and the binding entropySwas deduced
from the equation (G  H  TS). Experiments were per-
formed with protein concentrations
well within the recommended range
for the c-value (concentration of
protein in cell/Kd  100). Binding
paramaters were calculated as the
average of three independent exper-
iments mean S.E.
Immunofluorescence Staining and
Confocal Microscopy of PC12 Cells—
For rescue of Sx1a localization,
Munc18-1 knockdown PC12-KD43
cells were transfected with empty
pCMV5, pCMV5-Munc18-1-WT,
or pCMV5-Munc18-1-F115E/E132A
using Lipofectamine 2000 (Invitro-
gen). After 48 h, the cells were
briefly washed, fixed with 4%
paraformaldehyde and double-im-
munolabeled with anti-Munc18-1
(Synaptic Systems) and anti-
Syntaxin1a (HPC-1, Sigma) anti-
bodies followed by Alexa 488 and
Alexa 546 secondary antibodies
(Invitrogen), respectively. For NPY-
Venus and hGH colocalization
experiments, PC12-KD43 cells were
co-transfected with plasmids
pCMV-NPY-Venus and pXGH5-
hGH, expressing Venus-tagged
NPY and hGH, respectively. 48 h
after transfection, the cells were
washed, fixed (4% paraformalde-
hyde), and immunolabeled with
anti-hGH antibody, followed by
Alexa 546 secondary antibody. Cells
were visualized and images acquired
using a Zeiss LSM 510 Meta confo-
cal microscope as previously
described (27).
Human Placental Alkaline Phos-
phatase (hPLAP) Secretion Assay
from Co-transfected PC12 Cells—
Munc18-1 knockdown PC12 cells
(KD43) at 70–80% confluence in
10-cm dishes were co-transfected
with 2 g of pCMV-NPY-hPLAP
(to express NPY fused with soluble
human placental alkaline phospha-
tase) and 15 g of empty pCMV5
(for control) or pCMV-Munc18-1 (silentmutations) (for rescue
of the wild type or the indicated mutant) using electroporation
(25). After 48 h, the cells were harvested and re-plated in
24-well plates. 6 or 7 days after electroporation, the plated cells
were washed once with physiological saline solution (PSS) con-
taining 145 mM NaCl, 5.6 mM KCl, 2.2 mM CaCl2, 0.5 mM
MgCl2, 5.6 mM glucose, and 15 mM HEPES, pH 7.4, and NPY-
hPLAP secretion was stimulated with 200 l of PSS or high
K-PSS (containing 81 mM NaCl and 70 mM KCl). Secretion
FIGURE 1. The N-terminal interaction of Munc18-1 and Sx1a. A, the Munc18-1-Sx1a complex represented as
ribbon (left) and surface (right) models with the two key binding sites indicated. These involve the Sx1a N-terminal
peptide (residues2–9), andthecombinedSx1aHabcandH3domains (residues26–248).B, key residues required for
forming theSMprotein/N-peptide interaction in theMunc18c:Sx4-(1–29) crystal structure (top, PDBcode2PJX) (16)
arepresent intheMunc18-1:Sx1amodel (middle)andthenewlyrefinedMunc18-1:Sx1astructure (bottom,PDBcode
3C98)(20). Conserved hydrophobic residues defining the pocket are shown (blue). C, sequences of Syntaxin1a
(Homo sapiens, Rattus norvegicus, and Mus musculus), Syntaxin4 (H. sapiens, R. norvegicus, and M. musculus), and
Sed5p (S. cerevisiae) N termini were aligned. Conserved residues are highlighted (orange).
Munc18-1-SNARE Interaction in Neuroexocytosis
AUGUST 7, 2009•VOLUME 284•NUMBER 32 JOURNAL OF BIOLOGICAL CHEMISTRY 21639
was terminated after a 20-min incubation at 37 °C by chilling
to 0 °C, and samples were centrifuged at 4 °C for 3 min.
Supernatants were removed, and the pellets were solubilized
in 200 l of PSS containing 0.1% Triton X-100. The amounts
of NPY-hPLAP secreted into the medium and retained in the
cells were measured by the Phospha-Light Reporter Gene
Assay System (Applied Biosystems). Samples treated at 65 °C
for 30 min to inactivate non-placental alkaline phosphatases
and an aliquot (10 l) was assayed for placental alkaline
phosphatase activity with the kit. The total volume of the
assay was 120 l. After 5 to 10 min, chemiluminescence was
quantified by a FB12 luminometer (Berthold Detection
Systems).
hGH Release from Transfected PC12-KD43 or pSuper Cells—
PC12-KD43 cells were plated on a 6-well tissue culture plate
(Techno Plastic Plate). pXGH5 vector encoding hGH (1.6
g/well) either alone or together with mammalian expression
vectors encoding proteins as indicated in the figure (0.8
g/well) were co-transfected in PC12-KD43 cells with Lipo-
fectamine LTX (Invitrogen) in Opti-MEM I (Invitrogen)
according to the manufacturer’s instructions. 72 h after trans-
fection, PC12-KD43 cells were briefly washed with PSS and
either stimulatedwith PSS or highKPSS buffer (containing 81
mM NaCl and 70 mM KCl) for 20 min at 37 °C. Secretion was
terminated by chilling to 0 °C and supernatants were used for
the hGH assay as previously described (28). For totals, cells
were solubilized on ice in 1% Triton X-100 in PSS buffer con-
taining protease inhibitors (Calbiochem). The amount of secre-
tion from co-transfected cells was determined as the percent-
age of unstimulated hGH released using an hGH ELISA kit
(Roche Diagnostics) as previously described (29). Plotted data
are representative of three independent experiments, each car-
ried out in triplicate.
EvanescentWave Imaging—TIRF imaging was done using an
Olympus IX81 inverted microscope with a60 TIRF objective
and 1.45 N.A. objective illuminated with a 10-milliwatt argon
FIGURE 2.Munc18-1 mutants have reduced binding to Syntaxin1a. A, Munc18-1 representation showing the locations of the F115E, E132A, and F115E/
E132Amutations. B,Munc18-1 (WT andmutant) binding to Sx1a-His tethered toCo2-affinity beadswas analyzedbyCoomassie-stained SDS-PAGE.Munc18-1
mutant binding to Sx1a was reduced compared with Munc18-1-WT. C, Munc18-1 (WT and mutant) binding to Sx1a tethered to Co2-affinity beads was
quantified and compared (n 3). D, overlaid circular dichroism spectra measured for purified Munc18-1-WT (), Munc18-1-F115E (f), Munc18-1-E132A (Œ),
and Munc18-1-F115E/E132A () proteins.
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laser (Melles Griot). Images were captured using the
Hamamatsu ORCA1-ER camera controlled by Metamorph 5.0
software (Universal Imaging). Time-lapse images were
acquired every 5 s for 5 min at room temperature. PC12-KD43
cells were co-transfected with GFP-tagged human growth hor-
mone (hGH-GFP) and either pCMV5-Munc18-1-WT or
pCMV5-Munc18-1-F115E/E132A using Lipofectamine 2000
(Invitrogen). The cells were then plated on poly-L-lysine-coated
glass bottommicrowell dish (35 mm) (MatTek) and allowed to
express for 48 h. Cells were then washed in Buffer A (145 mM
NaCl, 5 mM KCl, 1.2 mM Na2HPO4, 20 mM HEPES-NaOH, pH
7.4) and imaged in Buffer A supplemented with Ca2 (2 mM).
Cells were stimulated using 100 M nicotine 30 s following the
onset of acquisition.
TIRF Image Analysis—Following TIRF image acquisition,
hGH-GFP-labeled granules entering the evanescence fieldwere
analyzed by particle tracking using Slidebook software (Version
4.2.0.13, Intelligent Innovation Imaging). The path lifetime of
single vesicle tracks was followed immediately after application
of nicotine until the disappearance of hGH-GFP-labeled vesi-
cles. The mean square displacement (MSD) of tracked vesicle
motion was calculated from the Slidebook software and plotted
against increment time interval. MSD plots can be fitted to
different equations describing vesiclemotions in three different
categories (30).
The simple diffusion motion is described by the following
linear equation,
MSD	t
 6Dt C (Eq. 1)
where C is an offset constant related to the accuracy of the
tracking algorithm.
From the second-order polynomial fit information about the
velocity v and diffusion coefficient D was obtained by fitting
MSD to,
MSD	t
 v2t2 6Dt C (Eq. 2)
The third case, restricted diffusion, is described by the follow-
ing equation in terms of the radius of the cage R, diffusion
coefficient, and two constants (a1 0.9, a2 0.85).
MSD	t
 R21 a1exp	6a2Dt/R
2
 6Dt C (Eq. 3)
When analyzing the MSD of hGH-GFP positive granules for
both Munc18-1-WT andMunc18-1-F115E/E132A, the best fit
was obtained with Equation 2. The velocity was therefore
extracted from Equation 2.
Image Processing and Data Analysis—Background correc-
tion and contrast adjustment of raw images were done either
using Adobe Photoshop CS2 (version 9) or SlideBook (version
4.2.0.13; Intelligent Imaging Innovations). Vesicle tracking and
analysis were performed using Slidebook and the results were
expressed as mean S.E.
Statistical Analysis—Data analysis was carried out using
unpaired Student’s t tests. Experiments were performed at least
3 times. Values are expressed as mean  S.E., and data are
considered significant at: *, p 0.05; **, p 0.01.
RESULTS ANDDISCUSSION
Defining the Munc18-1 Hydrophobic Pocket Interaction with
the Syntaxin1a N Terminus—Phe115 and Glu132 are key
Munc18-1 residues predicted to mediate the interaction
between the N-terminal peptide of Sx1a and a predominantly
hydrophobic pocket on the surface of Munc18-1 (Fig. 1). Ini-
tially, we used amodel of theMunc18-1-Sx1aN-terminal inter-
action and compared interactions with the crystal structure of
the closely related SM protein, Munc18c (Fig. 1B, top panel).
Our Munc18-1-Sx1a model (Fig. 1B, middle panel) was sup-
ported by the newly refined model for the crystal structure of
the Munc18-1-Sx1a complex recently reported by Burkhardt
and colleagues (22) (Fig. 1B, bottom panel). The key interaction
is formed between Munc18c/Phe119 and Sx4/Leu8 (17, 18),
which is conserved in theMunc18-1-Sx1a interaction (Fig. 1, B
andC) aswell as other SM:Syntaxin cognate partners exhibiting
the N-terminal binding mode (17). Furthermore, a conserved
DRTmotif of Sx1a (D3, R4, T5) has been shown to contribute to
interactions with Munc18-1 via the hydrophobic pocket (17,
22, 31). Based on the structural analysis, Glu132 can form an
FIGURE3.TheN-terminal interactionof Syntaxin1awithMunc18-1meas-
uredby ITC.Rawdata (toppanel) and integratednormalized ITCdata (bottom
panel) for binding of Sx1a-(2–243) to Munc18-1 WT (closed squares) and
Munc18-1-F115E/E132A (closed triangles). Experiments were performed by
injecting 3.1-l aliquots of 25MSx1a-(2–243) into 2.5MMunc18-1 proteins
at 298 K.
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electrostatic interaction with Arg4 in this motif. We aimed to
investigate the impact of two key Munc18-1 residues, Glu132
and Phe115, on binding to Sx1a. We constructed two point
mutants ofMunc18-1 at residue Phe115 (Munc18-1-F115E) and
at residue Glu132 (Munc18-1-E132A), as well as a double
mutant (Munc18-1-F115E/E132A), to disrupt the binding
pocket and examine their contribution to the interactions with
Sx1a alone and with the SNARE complex.
Mutations in the Munc18-1 Hydrophobic Pocket Alter Its
Binding to Syntaxin1a—We first compared the interaction of
Sx1a with our four Munc18-1 constructs: Munc18-1-WT,
Munc18-1-F115E, Munc18-1-E132A, and Munc18-1-F115E/
E132A. In addition, two other truncated Munc18-1 constructs
were tested for Sx1a binding,Munc18-1-dom1, which contains
only domain 1 of Munc18-1 (residues 1–132), and Munc18-1-
dom2/3, consisting of domains 2 and 3 only (residues 132–594)
(Fig. S1). His-tagged Sx1a was tethered to Co2-affinity beads
and incubated with de-tagged Munc18-1-WT and the three
mutants, then analyzed by SDS-PAGE (Fig. 2, A and B). In this
strategy, the GST tag was removed from the N terminus of the
Munc18-1 proteins and the Sx1a was tethered to the beads via
its C-terminal His tag.
As expected, Munc18-1-WT bound to Sx1a-His. However,
when compared with Munc18-1-WT, the Munc18-1 mutants
showed a significant reduction in Sx1a binding (Fig. 2B) or in
the case of the truncated mutants, no detectable binding to
Sx1a at all (Fig. S1). It should be noted that the point mutants
still displayed a relatively high affinity as discerned by the
strong intensity bands detected inCoomassie-stained gels. This
is not surprising considering the independent peptide binding
surface represents only 25% of the total buried surface area
when full-length Sx1a is bound to Munc18-1 (790 Å2 of a total
of 4940 Å2) (22). Neither of the truncated Munc18-1 proteins,
dom1 and dom2/3, bound to Sx1a-His indicating that the intact
full-lengthMunc18-1 protein is required (Fig. S1). The reduced
Sx1a binding observed for Munc18-1-F115E, Munc18-1-
E132A, and double mutant Munc18-1-F115E/E132A was
quantified and compared with WT Sx1a binding (n  3). The
Phe115mutation resulted in40% reduction in binding to Sx1a
compared with Munc18-1-WT (Fig. 2C), whereas the Glu132
mutation resulted in 30% decrease in binding to Sx1a (Fig.
2C). The double mutation resulted in a marked 65% reduc-
tion in binding to Sx1a compared with Munc18-1-WT (Fig.
2C). Circular dichroism analysis of the Munc18-1 point
mutants revealed no detectable secondary structure differences
compared with the Munc18-1-WT, eliminating the possibility
that reduced binding could be caused by a non-functional,
unfolded protein (Fig. 2D).
To further characterize these interactions and determine
whether the reduction in binding to Sx1a was a result of affinity
changes, ITC experiments were conducted. Sx1a-(2–243) was
titrated into either Munc18-1-WT or the Munc18-1-F115E/
E132A double mutant. Sx1a-(2–243) exothermically binds to
Munc18-1-WT with a dissociation constant (Kd) of 27.3 7.5
nM (Fig. 3, Table 1). This is higher than the Kd value of 1.4 nM
FIGURE 4.Munc18-1-WT but not Munc18-1-F115E or Munc18-1-F115E/
E132Abinds to the SNARE complex. A, assembled SNARE complex (com-
prising Sx1a-His, GST-SNAP25, and VAMP2) was isolated on Co2 affinity
beads, incubated with Munc18-1-WT or Munc18-1-F115E for 2 h at 4 °C.
Following extensive washing, beads were analyzed for bound proteins
using Coomassie-stained SDS-PAGE. Munc18-1-WT and Munc18-1-F115E
binding to the assembled SNARE complex was confirmed by analyzing
both boiled (95 °C for 5 min, denatured complex) and not boiled (SDS-
resistant complex) samples. B, Western blot of the SNARE complex-medi-
ated pulldown of Munc18-1-WT and Munc18-1-F115E/E132A probed with
anti-Munc18-1 antibody. C, the amount Munc18-1-WT and Munc18-1-
F115E/E132A binding to the SNARE complex on beads was averaged and
expressed as percentage of Munc18-1-WT binding (mean values  S.E.,
n  4).
TABLE 1
Thermodynamic parameters for the binding of Sx1a-(2–243) to Munc18-1 determined by ITC
Proteins interaction H TS G Kd n
kcal mol1 nM
Munc18-1-WT-Sx1a-(2–243) 19.98 0.88 9.59 1.04 10.39 0.20 27.27 7.51 1.05 0.01
Munc18-1-F115E/E132A-Sx1a-(2–243) 14.17 0.17a 3.79 0.28a 10.38 0.11 25.77 4.76 0.96 0.01
a Values were expressed as mean S.E. (n 3, p 0.01). See Experimental Procedures for sample concentrations used. All experiments were performed at 298 K.
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reported by Burkhardt et al. (22) but is in good agreement with
the 7.5–20.5 nM values obtained using ITC by Deak et al. (26),
and comparable with 10–20 nM values obtained by othermeth-
ods (31, 32). Interestingly, despite the reduced association
detected in pulldowns, the dissociation constant of the Sx1a
binding affinity to Munc18-1-F115E/E132A was not signifi-
cantly changed (25.77 4.76 nM) when compared with that of
Munc18-1-WT (Fig. 3, Table 1). In contrast, the binding
enthalpy (H) was significantly altered by the mutations, with
19.98  0.88 kcal/mol obtained for the Munc18-1-WT and
14.17  0.17 kcal/mol for Munc18-1-F115E/E132A (Fig. 3,
Table 1). This result is consistent with that of Burkhardt et al.
(22) who also observed a reduction of50% in the enthalpy of
binding when the Sx1a N-terminal peptide was removed.
Thermodynamically, the binding of Munc18-1-F115E/E132A
is characterized by a more favorable entropic contribution
(TS  5.3 kcal/mol). A possible explanation for the
decreased enthalpic and increased entropic contributions to
binding is that the overall binding surface area is reduced when
the Sx1a peptide is unable to bind, but there is a smaller
entropic penalty incurred by the folding of the unstructured
Sx1a N-terminal region upon association. Our results suggest
that the Munc18-1 mutant has altered binding kinetics to Sx1,
based on the reduced Sx1a binding observed in pulldowns,
which unlike ITC is not an equilibrium measurement. Surface
plasmon resonance experiments may be useful to probe these
binding kinetics further. Taken together our results indicate
that mutation of the Munc18-1 hydrophobic pocket, predicted
to mediate binding to the Sx1a N-terminal peptide, affects the
thermodynamics and kinetic properties of association, but sur-
prisingly does not cause a major change in the equilibrium
binding affinity.
Mutations in theMunc18-1 Hydrophobic Pocket Abrogate Its
Binding to the SNARE Complex—In view of the recent discov-
ery thatMunc18-1 binds to the SNARE complex, we next inves-
tigated the role of the Munc18-1 hydrophobic pocket in medi-
ating this interaction (6, 24). As previously demonstrated (6),
we found that Munc18-1-WT can bind to the ternary SNARE
complex (consisting of Sx1a, SNAP25, and VAMP2) (Fig. 4, A
and B). Importantly, a single mutation in theMunc18-1 hydro-
phobic pocket,Munc18-1-F115E, abrogatesMunc18-1 interac-
FIGURE 5. Munc18-1 restores membrane transport and localization of
Syntaxin1a in Munc18-1 knockdown PC12-KD43 cells. Representative
confocal images of PC12-KD43 cells transfected with pCMV5 empty vector
(top panel), pCMV5-Munc18-1-WT (middle panel), or pCMV5-Munc18-1-
F115E/E132A (bottom panels). Cells were fixed 48 h after transfection and
immunostained for Munc18-1 (green) and Sx1a (red). Scale bars, 10 m.
FIGURE 6. NPY secretion defects in Munc18-1 knockdown PC12-KD43
cells are rescued upon reintroduction of Munc18-1 (WT and the indi-
cated mutants) by transfection. A, immunoblot analysis of transfected
Munc18-1proteins in KD43 cells. 30mgof total homogenates fromKD43cells
electroporated with 20 g of the empty plasmid (pCMV5 as control) or the
plasmid that expresses Munc18-1 proteins were analyzed by SDS-PAGE and
immunoblotting using anti-Munc18-1 and anti-VCP/p97 antibodies. VCP/
p97, a ubiquitous membrane trafficking protein (42), was used as a loading
control. B, secretion of transfected NPY-hPLAP from the knockdown (KD43)
cells that were co-transfected with the control plasmid or the Munc18-1-WT,
Munc18-1-F115E, or Munc18-1-E132A expression plasmids (n 16). C, secre-
tion of NPY-hPLAP from the KD43 cells that were transfectedwith the control
plasmidor theMunc18-1-WTorMunc18-1-F115E/E132Aexpressionplasmids
(n  15). D, average secretion of transfected NPY-hPLAP from 5 different
clones of control PC12 cells (pSuper) that were co-transfected with the con-
trol plasmid. Data were expressed as mean S.E. and considered significant
at * p 0.05. ns, not significant.
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tion with the assembled SNARE complex (Fig. 4A). As
expected, the doublemutantMunc18-1-F115E/E132Awas also
unable to bind the assembled SNARE complex (Fig. 4,B andC).
The Munc18-1 hydrophobic pocket is therefore critical to
enable binding to the SNARE complex, an interaction that has
been shown to promote membrane fusion (6). This is in agree-
ment with recent reports demonstrating that the SNARE com-
plexes produced using either Sx1a containing the complemen-
tary Leu8mutation (6) or anN-terminal truncation of Sx1a (33)
do not interact with Munc18-1.
There are three key points of contact between Sx1a and
Munc18-1, involving the N-terminal peptide, Habc domain, and
SNAREH3helixofSx1a (22) (Fig. 1).As theH3helixwill beunable
toparticipate inMunc18-1bindingwhencomplexedwithcognate
SNAREs, it is expected that the relative contributions of the Habc
domain and N-terminal peptide will be significantly increased
whenassociatedwithSNAREcomplexes. In supportof this, recent
work by Deak and colleagues (26) examined specific mutations in
the Munc18-1 protein contacting the Sx1a Habc domain, and
found that they are important for SNAREcomplex associationbut
do not significantly affect binding to free Sx1a. These results
almost perfectly mirror our own experiments analyzing the
importance of the Sx1aN-terminal peptide interface, and support
a model whereby Munc18-1 has at least two productive binding
modes, a high affinity mode utilizing all three Sx1a conserved
domains, and a lower affinitymode utilizing only Sx1aN-terminal
peptide and Habc domains that is
important for Munc18-1 association
with SNARE complexes. Evidence
also suggests that VAMP2, within the
SNARE complex, may interact
directly with Munc18-1 and that
these interactions are involved in
exerting a positive regulatory role on
SNARE-mediated fusion (6, 33, 34).
In summary our results demonstrate
that the hydrophobic pocket of
Munc18-1 is essential for interaction
with the assembled SNARE complex
and contributes to a lesser extent to
the free Sx1a binding.
Expression of the Munc18-1 Dou-
ble Mutant Lacking the Interaction
with Sx1a N Terminus Rescues the
Plasma Membrane Localization of
Syntaxin1a in PC12-KD43 Cells—
Having demonstrated that muta-
tions in key residues of the
Munc18-1 hydrophobic pocket
impaired SNARE complex binding
(and to a lesser extent association
with free Sx1a), we investigated the
functional significance of this inter-
action. Converging lines of evidence
have recently shown thatMunc18-1
facilitates Sx1a targeting to the
plasma membrane (10, 25, 35).
Moreover, a switch in the Munc18-
1-Sx1a interaction has been found to occur at the level of the
plasma membrane (10). In the vicinity of the plasma mem-
brane, Munc18-1 binding mainly occurs through the N termi-
nus of Sx1a, thereby favoring the subsequent interaction of
Sx1a with SNAP-25 (10). This raises the question as to whether
theN-terminal interaction is necessary and/or sufficient for the
actual delivery of Sx1 to the plasma membrane. We therefore
examined whether the Munc18-1 double mutant lacking the
ability to bind to the N terminus of Sx1a was capable of deliv-
ering Sx1a to the plasma membrane. The knockdown of
Munc18-1 in PC12-KD43 cells greatly affects the delivery of
Sx1a to the plasma membrane (Fig. 5) as previously reported
(25). In these cells, expression of Munc18-1-WT efficiently
restores plasmamembrane localization (Fig. 5) as shown previ-
ously (25). Surprisingly, expression ofMunc18-1-F115E/E132A
was also capable of delivering Sx1a to the plasma membrane
(Fig. 5, Fig. S2). This result does not support amajor role for the
N-terminal interaction in the actual delivery of Sx1a to the
plasma membrane.
Expression of SNARE Binding-deficient Munc18-1 Mutants
Rescues Exocytosis in PC12 Cells Lacking Munc18-1—We next
examined whether Munc18-1-WT and mutants were capable
of restoring secretion when expressed in Munc18-1 knock-
down (KD43) PC12 cells. These cells were co-transfectedwith a
reporter plasmid allowing the expression of NPY fused with a
soluble domain (residues 18–506) of hPLAP, which can be
FIGURE 7.hGHsecretiondefects inMunc18-1 knockdownPC12-KD43 cells are rescuedupon reintroduc-
tion ofMunc18-1 (WT and doublemutant) by transfection. A, Munc18-1 knockdown PC12 KD43 cells were
co-transfected with NPY-Venus and hGH and immunostained with anti-hGH (red) and visualized by confocal
microscopy. NPY-Venus (yellow) co-localizes with hGH in secretory vesicles. Scale bar, 10 m. B, Munc18-1
knockdown PC12-KD43 cells transiently transfectedwith hGH and control plasmid (pCMV5), Munc18-1-WT, or
Munc18-1-F115E/E132A were incubated for 20 min in the absence or presence of high K to stimulate exocy-
tosis. hGH release is expressed as thepercentageof hGH released in unstimulated conditions. Data are given as
themean S.E. (n 3) and are representative of results obtained in three independent experiments. n.s., not
significant (Student’s t test; n 3).
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secreted in a Ca2-dependent manner and quantified by meas-
urements of alkaline phosphatase activity of hPLAP as previ-
ously described (25). Expression of Munc18-1-WT rescued the
secretion of NPY-hPLAP by 71.5  8.1% (Fig. 6, A–C).
Munc18-1-WT overexpression is also known to rescue exocy-
tosis in Munc18-1 knock-out chromaffin cells (36, 37). Expres-
sion of Munc18-1-F115E produced a significant rescue of exo-
cytosis, albeit slightly reduced when compared with the rescue
generated byMunc18-1-WT (Fig. 6B). Importantly, expression
of Munc18-1-E132A and Munc18-1-F115E/E132A was also
able to fully rescue exocytosis (Fig. 6A), with the functional
rescue not significantly different from that of Munc18-1-WT
(Fig. 6, B and C). The level of secretion in control PC12 cells
(Psuper) is indicated in Fig. 6D.
We next checked whether this result could be reproduced
using the stimulated release of another hormone. PC12-KD43
cells were first transfected with NPY-Venus and hGH. Cells
were processed for hGH immunoreactivity and imaged by con-
focal microscopy. As expected, NPY-Venus staining over-
lapped with hGH immunoreactivity (Fig. 7A), demonstrating
that both overexpressed hormones were packaged in the same
secretory vesicles. PC12-KD34 cells were next co-transfected
with hGH and either Munc18-1-WT or Munc18-1-F115E/
E132A. Both Munc18-1-WT and Munc18-1-F115E/E132A
were capable of rescuing depolarization-induced hGH release
(Fig. 7B). Furthermore, no significant differences were found in
the WT and mutant rescuing effect (Fig. 7B), thereby confirm-
ing our original finding using NPY release.
Although the release of NPY and hGHwas rescued to a large
extent in PC12-KD43 cells upon expression of Munc18-1-
F115E/E132A, our experiment did not allow deeper examina-
tion of the actual process of exocytosis. To investigate this fur-
ther, evanescent wave imaging was conducted. PC12-KD43
cells were co-transfected with hGH-GFP and either Munc18-
1-WT or Munc18-1-F115E/E132A. Both Munc18-1-WT or
Munc18-1-F115E/E132A were able to restore hGH-GFP exo-
cytosis in these cells (Fig. 8,A andB). Noticeably, during a short
window of time following nicotine stimulation, the rate of
fusion of the hGH-GFP vesicle in cells expressing Munc18-1-
F115E/E132A was significantly slower than in cells expressing
Munc18-1-WT (Fig. 8, B and C). However, this effect was tran-
sient and no significant difference was detected at longer time
points. Immediately after stimulation, the hGH-GFP-positive
vesicle path lifetime (residence time) of Munc18-1-F115E/
E132A-expressing cells was increased as compared with that of
Munc18-1-WT-expressing cells (Fig. 8D). Although the differ-
ence path lifetime was not significant, the velocity of hGH-
GFP-positive vesicles was significantly reduced in Munc18-1-
F115E/E132A-expressing cells (Fig. 8E).
The effect of Munc18-1-F115E/E132A on the rate of vesicle
fusion and their path lifetime and velocity was only transient
and the overall impact of these changes to the release of hGH
and NPY was barely detectable. However, it is likely that such
changes in the kinetic behavior of large dense core vesicles
could produce more dramatic effects in phasic neurotransmit-
ter release from neurons. Indeed, efficient neurotransmitter
release relies on the synchronous release ofmany small synaptic
vesicles. This process is highly dependent on the timing of
vesicular fusion and is greatly affected by botulinum neurotox-
in-induced VAMP2 cleavage (38) or through genetic alteration
of Synaptotagmin 1 (39). Furthermore, two recent studies have
found that mutations ofMunc18-1 that also alter SNARE com-
plex binding do not rescue phasic neurotransmitter release in
Munc18-1 knock-out mice and Unc18-null Caenorhabditis
elegans (26, 40). However, in these cortical neurons isolated
from the Munc18-1 KO mice, the effect was attributed to a
reduction in the readily releasable pool of synaptic vesicles.
FIGURE 8. Munc18-1 rescues hGH-GFP exocytosis in Munc18-1 knock-
down PC12-KD43 cells. A, footprint of Munc18-1 knockdown cells express-
ing hGH-GFP and co-transfected with Munc18-1-WT or Munc18-1-F115E/
E132A as indicated. The arrows indicate the vesicles highlighted in B. B, time
series of single vesicles. The vesicle in cells transfected with Munc18-1-WT
fused 40 s following nicotine stimulation (100 M). Fusion of the vesicle
from cells expressing Munc18-1-F115E/E132A was significantly delayed.
C, time course of hGH-GFP positive vesicle fusion following nicotine stimula-
tion at time 0 s. Vesicle fusion in cells expressing Munc18-1-WT (n 11 cells)
was significantly more rapid at the onset of stimulation compared with vesi-
cles in cells expressingMunc18-1-F115E/E132A (n 11 cells).D, path lifetime;
and E, velocity of hGH-GFP positive vesicles in cells expressingMunc18-1-WT
(n 11 from 5 cells) andMunc18-1-F115E/E132A (n 37 from 8 cells) follow-
ing nicotine stimulation. Data are normalized to the Munc18-1-WT value,
expressed as mean S.E. and significant at *, p 0.05 (unpaired Student’s t
test).
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Bearing inmind the effect ofMunc18-1 on the fusion pore (41),
an alternative possibility is that theMunc18-1mutations affect-
ing SNARE complex binding could affect the duration of open-
ing of the fusion pore. Clearly more work is required to inves-
tigate the nature of these differences.
Despite the newly proposed theory that the Sx1a N-terminal
interaction with Munc18-1 is critical for SNARE complex-in-
duced fusion of exocytic vesicles (6, 31), our results indicate
that this does not contribute to Sx1a delivery to the plasma
membrane and has only a limited impact on Ca2-dependent
neuroexocytosis in PC12 cells. It will be interesting to deter-
mine whether genetically ablating this interaction has more
functional consequences in an animal model.
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